ArticleBJS open2025
Clinical implications of an intraoperative margin-positive distal bile duct in perihilar cholangiocarcinoma: international multicentre cohort study.
Article in BJS open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe short- and long-term outcomes of intraoperative extension of the distal bile duct margin following a positive frozen section in patients with perihilar cholangiocarcinoma remain poorly characterized.
methodsBetween 1 January 2003 and 1 January 2023, consecutive patients at seven high-volume European hepatopancreatobiliary centres undergoing major hepatectomy for perihilar cholangiocarcinoma with frozen-section analysis of the distal bile duct and subsequent intraoperative management were included retrospectively. The primary endpoint was achievement of an overall R0 resection following distal bile duct re-resection or additional pancreatoduodenectomy after identification of a positive distal bile duct frozen section. Secondary endpoints included overall survival, disease-free survival, and major postoperative complications (Clavien-Dindo grade ≥ IIIa). Outcomes were reported as adjusted hazard ratios.
resultsOf 785 patients undergoing major hepatectomy for perihilar cholangiocarcinoma, 594 underwent distal bile duct frozen-section analysis. A total of 66 (11.1%) intraoperative frozen sections were positive for invasive carcinoma, with an additional 7 (1.2%) false-negative findings. Distal bile duct re-resection was performed in 49 patients (74%), and 11 (16%) underwent additional pancreatoduodenectomy. Among these, 46 patients (69%) achieved distal bile duct margin clearance, with 30 (45%) ultimately attaining overall R0 resection. Overall survival was similar for patients who achieved overall R0 status via distal bile duct re-resection or pancreatoduodenectomy and those with overall R0 margins after primary negative distal bile duct frozen section (adjusted hazard ratio 0.84, 95% confidence interval 0.49 to 1.44; P = 0.536). Conversely, overall R1 resection was associated with significantly worse overall survival (adjusted hazard ratio 1.82, 1.43 to 2.33; P < 0.001). Complications graded ≥ IIIa and 90-day mortality did not differ significantly between groups undergoing distal bile duct re-resection, pancreatoduodenectomy or no intervention (P = 0.126 and P = 0.121, respectively).
conclusionIn selected patients, re-resection or additional pancreatoduodenectomy after positive distal bile duct frozen-section analysis is associated with long-term survival without significantly increasing major morbidity or mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.